Literature DB >> 4350014

Ventilatory effects of aerosolized kanamycin and polymyxin.

K J Dickie, W J De Groot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4350014     DOI： 10.1378/chest.63.5.694

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Bronchial reactivity to inhaled polymyxin B in subjects with asthma and chronic obstructive bronchitis.

Authors:  P Górski; J Rozniecki; M Szmidt
Journal:  Lung       Date:  1979       Impact factor: 2.584

3.  Inhalation of polymyxin B as a bronchial provocation method.

Authors:  J Rozniecki; P Gorski
Journal:  Lung       Date:  1978       Impact factor: 2.584

4.  Pulmonary function and histaminemia after polymyxin B inhalation.

Authors:  P Górski; J Rozniecki; M Szmidt; I Rychlicka
Journal:  Agents Actions       Date:  1981-04

5.  Ventilatory effects of aerosol gentamicin.

Authors:  M B Dally; S Kurrle; A B Breslin
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

Review 6.  Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.

Authors:  Cordula Koerner-Rettberg; Manfred Ballmann
Journal:  Core Evid       Date:  2014-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.